Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MCT oil (medium-chain triglyceride oil) is a dietary supplement composed of triglycerides containing fatty acids with aliphatic tails of 6 to 12 carbon atoms. In the context of the ANANDA clinical trial (RBR-6n6wzsx) conducted by the Universidade do Sul de Santa Catarina, MCT oil is utilized as a placebo comparator in a study evaluating full-spectrum cannabidiol (CBD) oil for treatment-resistant major depressive disorder. It is chosen for its physical similarity to CBD oil in appearance and texture, allowing for effective blinding of participants and investigators. While MCT oil is used nutritionally to provide a rapid energy source or as part of a ketogenic diet, it lacks a specific pharmaceutical target or therapeutic indication for psychiatric disorders in this context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on medium-chain triglyceride oil.